Loading chat...
AL HB127
Bill
Status
1/13/2026
Primary Sponsor
Chip Brown
Click for details
AI Summary
-
State Board of Pharmacy prohibited from revoking, suspending, or taking adverse action against a pharmacist's license solely for recommending or dispensing off-label medications prescribed by a licensed health care professional
-
Pharmacy employers prohibited from terminating or disciplining pharmacists for recommending or dispensing off-label medications, with pharmacists granted a civil cause of action for injunctive relief, reinstatement, back pay, and attorney fees if violated
-
Pharmacy benefits managers prohibited from retaliating against pharmacists or their employing pharmacies for off-label dispensing, including contract cancellation, breach of contract lawsuits, or initiating audits
-
Ivermectin (suitable for human use) and Hydroxychloroquine authorized for over-the-counter sale without a prescription or health care consultation
-
Protections do not apply to controlled substances or off-label uses that have not been adequately tested on humans; effective date October 1, 2026
Legislative Description
Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.
Occupational Licensing Boards
Last Action
Pending House Health
1/13/2026